Ribometrix
Ribometrix, a US-based biotech firm, leverages 3D RNA analysis for novel drug discovery.
Founded
2014Ribometrix, a US-based biotech firm, leverages 3D RNA analysis for novel drug discovery.
Ribometrix, founded in Durham, North Carolina, is a biotechnology company specializing in the three-dimensional structural analysis of RNA to drive its proprietary drug discovery platform. The company's core mission is to pioneer a new paradigm in drug discovery by targeting RNA biology with small molecules to prevent the production of disease-causing proteins. Ribometrix focuses on developing novel therapeutics for a range of diseases, leveraging its advanced RNA analysis capabilities to identify unique drug targets.
Notable figures affiliated with Ribometrix include leading scientists and experts in RNA biology. The company has attracted significant investment from prominent biotech investors, enabling it to advance its research and development efforts. Key achievements include the development of a robust pipeline of potential therapeutics and strategic partnerships with major pharmaceutical companies. Ribometrix's innovative approach has the potential to transform the landscape of drug discovery, offering new hope for treatments of previously intractable diseases.
Companies similar to Ribometrix include Nymirum, Remix Therapeutics, Ribonova and Wayfinder Biosciences.
Ribometrix was founded in 2014.
Ribometrix's headquarters is located in Greenville, NC, US.
Ribometrix's most recent funding round was for $7.8M (USD) in September 2019.
As of Sep 27, 2019, Ribometrix has disclosed funding of $45.3M (USD). Undisclosed round amounts are excluded.
Ribometrix has 29 employees as of Feb 5, 2024.
Wayfinder Biosciences
wayfinderbio.com
